A previous study reported that EET produced from CYP2J2 is important for cancer metastasis in breast cancer [17]; however, other studies have reported that CYP2J2 is not associated with overall survival, and that its immunoactivity is nearly undetectable in breast cancer tissues [18, 19]. Here, CYP2J2 is linked to breast carcinoma.